| Q36254717 | A glioma-derived analog to platelet-derived growth factor: demonstration of receptor competing activity and immunological crossreactivity |
| Q52071909 | A quantitative model for differential motility of gliomas in grey and white matter. |
| Q41456514 | Aberrations of growth factor control in metastatic follicular thyroid cancer in vitro |
| Q55488495 | Activation of Amiloride-Sensitive Sodium Transport in C6 Glioma Cells |
| Q37761398 | Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma |
| Q41703007 | Binding of epidermal growth factor (EGF) to a cultured human glioma cell line |
| Q55484170 | Binding of epidermal growth factor-dextran conjugates to cultured glioma cells |
| Q55472858 | Cellular retention of radioactivity and increased radiation dose. Model experiments with EGF-dextran |
| Q72405313 | Coexpression of a PDGF-like growth factor and PDGF receptors in a human osteosarcoma cell line: Implications for autocrine receptor activation |
| Q33206782 | Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer |
| Q41192340 | Divergent effect of TGFbeta1 on growth and proteolytic modulation of human prostatic-cancer cell lines |
| Q40801239 | EGF receptor in neoplasia and metastasis |
| Q48690139 | EGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiation |
| Q55485073 | Early and late passage C-6 glial cell growth: similarities with primary glial cells in culture. |
| Q41713269 | Effects of 131I-EGF on cultured human glioma cells |
| Q48417875 | Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells |
| Q41647145 | Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture |
| Q48646011 | Epidermal growth factor is a motility factor for microglial cells in vitro: evidence for EGF receptor expression |
| Q68811857 | Epidermal growth factor--receptors on cultured human meningioma cells |
| Q36230414 | Epithelial cell guidance by self-generated EGF gradients. |
| Q42452739 | Expression of heparin-binding epidermal growth factor-like growth factor in rat brain |
| Q28740473 | Gefitinib induces epidermal growth factor receptor dimers which alters the interaction characteristics with ¹²⁵I-EGF |
| Q35920513 | Glioblastoma--a moving target. |
| Q48138801 | Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines |
| Q40596119 | Growth factor-induced cell migration: biology and methods of analysis |
| Q41442987 | Growth factors in bladder cancer |
| Q73317705 | Her2/neu overexpression in differentiated thyroid carcinomas predicts metastatic disease |
| Q97543429 | Identification of functionally distinct and interacting cancer cell subpopulations from glioblastoma with intratumoral genetic heterogeneity |
| Q35085398 | In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation |
| Q41941723 | Influence of Chloroquine and Lidocaine on Retention and Cytotoxic Effects of [131I]EGF: Studies on Cultured Glioma Cells |
| Q40968600 | Inhibition of phospholipase C-gamma1 activation blocks glioma cell motility and invasion of fetal rat brain aggregates |
| Q68127085 | Liver epithelial cell migration induced by epidermal growth factor or transforming growth factor alpha is associated with changes in the gene expression of secreted proteins |
| Q41687856 | Mitogens as motogens |
| Q53437403 | Modulation of phenotype and induction of irregular vessels accompany high tumorigenic potential of clonal human glioma cells xenografted to nude-rat brain. |
| Q40048012 | Multiscale agent-based cancer modeling |
| Q38820099 | NPM1 histone chaperone is upregulated in glioblastoma to promote cell survival and maintain nucleolar shape. |
| Q39815572 | Nuclisome: a novel concept for radionuclide therapy using targeting liposomes. |
| Q38003175 | PDGF and PDGF receptors in glioma. |
| Q35839346 | Post-radiation increase in VEGF enhances glioma cell motility in vitro |
| Q35977349 | Prognostic impact of EGF-receptor in papillary thyroid carcinoma |
| Q48364783 | Quantitative assessment of glioblastoma invasion in vivo |
| Q34303359 | Quantitative proteomic analysis reveals effects of epidermal growth factor receptor (EGFR) on invasion-promoting proteins secreted by glioblastoma cells |
| Q27319526 | Regulation of brain tumor dispersal by NKCC1 through a novel role in focal adhesion regulation |
| Q38292832 | Resolving the EGF-EGFR interaction characteristics through a multiple-temperature, multiple-inhibitor, real-time interaction analysis approach |
| Q39438246 | Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation. |
| Q43166122 | Simulating Brain Tumor Heterogeneity with a Multiscale Agent-Based Model: Linking Molecular Signatures, Phenotypes and Expansion Rate |
| Q71646046 | Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor |
| Q41322756 | Substrates for astrocytoma invasion |
| Q39877743 | Targeting malignant glioma cells in vitro using platelet-derived growth factor AA-based conjugates |
| Q73124685 | Tumor-cell targeted epiderimal growth factor liposomes loaded with boronated acridine: uptake and processing |
| Q42809195 | Tumorigenic, invasive, karyotypic, and immunocytochemical characteristics of clonal cell lines derived from a spontaneous canine anaplastic astrocytoma |
| Q33951992 | What role(s) for TGFalpha in the central nervous system? |